Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells

Analyst. 2014 Dec 21;139(24):6414-20. doi: 10.1039/c4an01642d.

Abstract

Here we synthesized silica-coated NaYF4:Yb,Tm@NaGdF4 nanoparticles with hypocrellin photosensitizers covalently incorporated inside the silica shells, combining dual modal imaging and photodynamic therapy (PDT) functions together. Under excitation at 980 nm, the tumor-targeting specificity of the as-prepared nanomaterials efficiently enhanced as folic acid (FA) was conjugated. The internalization of UCNPs@SiO2@hypocrellin A-FA in HeLa cells and HEK-293 cells was observed by confocal microscopy and in vitro magnetic resonance imaging (MRI), which demonstrated that the as-prepared nanocomposites have the ability to target folate receptor (FR) (+) cells. Moreover, magnetic resonance (MR) measurements also demonstrated that the as-prepared nanocomposites could be used as a contrast agent for MRI. All these results showed the feasibility and potential of the as-prepared nanocomposites for simultaneous imaging and PDT application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contrast Media* / chemistry
  • Fluorides / chemistry
  • Gadolinium / chemistry
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Magnetic Resonance Imaging
  • Microscopy, Confocal
  • Nanoparticles / chemistry
  • Nanoparticles / therapeutic use*
  • Neoplasms / diagnosis
  • Neoplasms / therapy
  • Perylene / analogs & derivatives*
  • Perylene / therapeutic use
  • Phenol
  • Photochemotherapy
  • Photosensitizing Agents / therapeutic use*
  • Quinones / therapeutic use*
  • Silicon Dioxide / chemistry
  • Yttrium / chemistry

Substances

  • Contrast Media
  • Photosensitizing Agents
  • Quinones
  • sodium yttriumtetrafluoride
  • Phenol
  • Yttrium
  • Perylene
  • Silicon Dioxide
  • Gadolinium
  • Fluorides
  • hypocrellin A